¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"breath analysis test"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • sign test
    ºÎÈ£°ËÁ¤
  • skin-window test
    ÇǺÎâ¹®°Ë»ç
  • venereal disease research laboratory test
    ¸Åµ¶Ç÷û°Ë»ç, VDRL°Ë»ç
  • vestibular function test
    ¾È¶ã±â´É°Ë»ç, ÀüÁ¤±â´É°Ë»ç
  • visual acuity test
    ½Ã·Â°Ë»ç
  • visual acuity test chart
    ½Ã·Â°Ë»çÇ¥
  • Widal test
    À§´Þ°Ë»ç
  • word association test
    ´Ü¾î¿¬»ó°Ë»ç
  • water deprivation test
    ¼öºÐÁ¦ÇѰ˻ç
  • Weil-Felix test
    ¹ÙÀÏ-Æç¸¯½º°Ë»ç
  • Western blot test
    ¿þ½ºÅϺí·Ô°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • latex agglutination test
    ¶óÅØ½ºÀÀÁý½ÃÇè, ¶óÅØ½ºÀÀÁý¹ÝÀÀ°Ë»ç
  • latex fixation test
    ¶óÅØ½º°íÁ¤¹ÝÀÀ°Ë»ç
  • lepromin test
    ·¹ÇÁ·Î¹Î°Ë»ç
  • lethal titer test
    Ä¡»çÁ¤·®°Ë»ç
  • litmus test
    ¸®Æ®¸Ó½º½ÃÇè, ¸®Æ®¸Ó½º°Ë»ç
  • liver function test
    °£±â´É°Ë»ç
  • lymphoblastic transformation test
    ¸²ÇÁ¸ð¼¼Æ÷Àüȯ°Ë»ç
  • macrophage migration test
    Å«Æ÷½Ä¼¼Æ÷À̵¿°Ë»ç
  • maximal stimulation test
    ÃÖ´ëÀڱذ˻ç
  • mental test
    Áö´ÉÃøÁ¤
  • metabolism test
    ´ë»ç½ÃÇè
  • migration inhibition test
    À̵¿¾ïÁ¦°Ë»ç, À̵¿ÀúÁö°Ë»ç
  • minimal nerve excitability test
    ÃּҽŰæÀڱذ˻ç
  • minimal stimulating test
    ¹Ì¾àÁÖÀÔÀڱؽÃÇè
  • mixed lymphocyte culture test
    È¥ÇÕ¸²ÇÁ±¸¹è¾ç°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • alternate prism cover test
    ±³´ëÇÁ¸®Áò°¡¸²°Ë»ç
  • ames test
    ¿¡ÀÓ½º°Ë»ç(¡­ËþÞÛ)
  • anesthetic test of pulp
    Ä¡¼ö¸¶Ãë°Ë»ç.
  • antibody absorption test
    Ç×üÈí¼ö½ÃÇè(ù÷ô÷ýåâ¥ãËúÐ).
  • antibody identification test
    Ç×üȮÀΰ˻ç
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • anticomplement immunofluorescent test
    Ç׺¸Ã¼¸é¿ªÇü±¤½ÃÇè.
  • antiformin test
    ¾ÈƼÆ÷¸£¹Î½ÃÇè.
  • antiglobulin test
    Çױ۷κҸ°½ÃÇè.
  • antiglobulin test
    Çױ۷κҸ°½ÃÇè
  • antiglobulin test, direct
    Á÷Á¢ Çױ۷κи° °Ë»ç
  • antiglobulin test, indirect
    °£Á¢Çױ۷κҸ° °Ë»ç
  • antimicrobial susceptibility test
    Ç×±Õ¹°Áú °¨¼ö¼º(ù÷жڪòõÊïáôàõ)½ÃÇè.
  • antimicrobial susceptibility test
    Ç×±Õ¹°Áú °¨¼ö¼º(ù÷жڪòõÊïáôàõ)½ÃÇè.
  • antimicrobial susceptibility test
    Ç×±ÕÁ¦°¨¼ö¼º½ÃÇè
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • blanching test
    Ç¥¹é½ÃÇè.
  • blank test
    °ø½ÃÇè(ÍöãËúÐ).
  • bleeding time test
    ÃâÇ÷½Ã°£½ÃÇè(?Ëà˧ËàÌ´).
  • bleeding time test
    ÃâÇ÷½Ã°£½ÃÇè(¡­ãÁÊàãËúÐ).
  • blind folded vertical writing test
    Â÷¾È¼­ÀÚ°Ë»ç, ½Ã¾ßÂ÷´ÜÈÄ Çʱâ
  • blocking test
    Â÷´Ü½ÃÇè(ó´Ó¨ãËúÐ).
  • blood coagulation test
    Ç÷¾×ÀÀ°í½ÃÇè (?ËàÌ´).
  • blood coagulation test
    Ç÷¾×ÀÀ°í½ÃÇè (¡­ãËúÐ).
  • blood sugar test
    Ç÷´ç°Ë»ç(úìÓØËþÞÛ).
  • blood test
    Ç÷¾×°Ë»ç(¹ý).
  • boiling test
    ²úÀÓ½ÃÇè(¡­ãËúÐ).
  • bone conduction test
    °ñµµ °Ë»ç(ÍéÓôËþÞÛ).
  • bone marrow function test
    °ñ¼ö±â´É°Ë»ç (¡­Ñ¦ÒöËþÞÛ).
  • breakdown test
    ÆÄ±«½ÃÇè(¡­ãËúÐ).
  • brucellosis test
    ºê·ç¼¿¶óÁõ½ÃÇè.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
CUA cost-utility analysis [ratio]
DDA Dangerous Drugs Act; dideoxyadenosine; digital differential analysis
DFA direct fluorescent antibody; discriminant function analysis; dorsiflexion assistance
DTA differential thermal analysis; diphtheria toxin A
ECTA esophageal gastric tube airway; Everyman's Contingency Table Analysis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
REA Restriction Endonuclease Analysis
REA Restriction enzyme analysis
RFLP Restriction fragment length polymorphism analysis
RSA Roentgen Stereophotogrammetric Analysis
SAGE Serial Analysis of Gene Expression
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • exoantigen test
    ¿ÜÇ׿ø ½ÃÇè
  • Fantus test
    ÆÇÅͽº ½ÃÇè
  • Farber's test
    ÆÄÀ̹ö ½ÃÇè
  • Farnworth D-15 test
    ÆÄ¸¥¿ö½º 15»ö»ó °Ë»ç
  • Farr test
    ÆÄ¾Æ¸£ ½ÃÇè
  • femoral nerve stretch test
    ´ëÅð ½Å°æ ½ÅÀü ½ÃÇè
  • fermentation test
    ¹ßÈ¿ ½ÃÇè
  • ferric chloride test
    ¿°È­ Á¦2ö ½ÃÇè
  • fibrinogen consumption test
    ¼¶À¯¼Ò¿ø ¼Òºñ ½ÃÇè
  • finger to nose test
    ¼Õ°¡¶ô-ÄÚ ½ÃÇè
  • finger-nose test
    ¼Õ°¡¶ô-ÄÚ ½ÃÇè
    ÆÈÀ» ¿ÞÂÊÀ̳ª ¿À¸¥ÂÊÀ¸·Î Æì°í, Áý°Ô¼Õ°¡¶ô ³¡À» ¼­¼­È÷ ÄÚ ³¡¿¡ ´ëµµ·Ï ÇǰËÀÚ¿¡°Ô Áö½ÃÇÑ´Ù.
  • finger-to-finger test
    ¼Õ°¡¶ô-¼Õ°¡¶ô ½ÃÇè
  • Fishberg concentration test
    Çǽ¬¹ö±× ³óÃà ½ÃÇè
    200§¢ ÀÌÇÏÀÇ ¾×ü°¡ µé¾î°£ Àú³á ½Ä»ç¸¦ ÇǰËÀÚ¿¡°Ô ÁÖ°í, ÀÌÈÄ¿¡´Â ¾Æ¹« °Íµµ ÁÖÁö ¾Ê´Â´Ù. ¾ß°£¿¡ ¹è¼³µÈ ¿ä´Â ¹ö¸®°í À̸¥ ¾ÆÄ§ÀÇ ¿ä¸¦ ¸ð¾Æ³õ°í, ÇǰËÀÚ´Â ÀáÀ» Àڸ鼭 1½Ã°£ ÈÄ¿Í 2½Ã°£ ÈÄÀÇ ¿ä¸¦ äÃëÇÑ´Ù. ÀÌ 3°¡ÁöÀÇ ¿ä Ç¥º» Áß ¾î´À Çϳª¶óµµ ºñÁßÀÌ 1.024 ¹Ì¸¸ÀÌ¸é ½Å ±â´É ºÎÀüÀÌ´Ù.
  • fistula test
    ´©°ø °Ë»ç, ´©°ø ½ÃÇè
  • flicker fusion test
    ÇÁ¸¯Ä¿ À¶ÇÕ °Ë»ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
Master's two-step exercise test An early and long-used exercise challenge to identify ischemic heart disease using a pair of nine inch steps with a platform on top, the number of trips by the patient arbitrarily chosen and related to age and body weight.
See: two-step exercise test.
Synonym: Master's two-step exercise test.
(05 Mar 2000)
Master test An early and long-used exercise challenge to identify ischemic heart disease using a pair of nine inch steps with a platform on top, the number of trips by the patient arbitrarily chosen and related to age and body weight.
See: two-step exercise test.
Synonym: Master's two-step exercise test.
(05 Mar 2000)
red cell adherence test The diagnostic application of the immune adhesion phenomenon.
Synonym: erythrocyte adherence test, immune adhesion test, red cell adherence test.
(05 Mar 2000)
Casoni intradermal test A test for hydatid disease in which hydatid fluid is injected intracutaneously; immediate or delayed wheal and flare reaction is positive.
Synonym: Casoni skin test.
(05 Mar 2000)
Casoni skin test A test for hydatid disease in which hydatid fluid is injected intracutaneously; immediate or delayed wheal and flare reaction is positive.
Synonym: Casoni skin test.
(05 Mar 2000)
red test An obsolete test for renal function; after the patient has drunk a glass or two of water, 1 ml of a 0.6% solution of dye is injected hypodermically; the time between this injection and the appearance of a pink tinge in the urine as it falls into an alkaline solution is noted; the amount excreted in each of the next 2 hours is then estimated colourimetrically.
Synonym: Geraghty's test, phthalein test, red test, Rowntree and Geraghty test.
(05 Mar 2000)
viability test <investigation> Test to determine the proportion of living individuals, cells or organisms, in a sample. Viability tests are most commonly performed on cultured cells and usually depend on the ability of living cells to exclude a dye, (an exclusion test) or to specifically take it up (inclusion test).
(18 Nov 1997)
Mauthner's test An obsolete test for colour perception similar to Holmgren's, but made with vials filled with pigments instead of with skeins of wool.
(05 Mar 2000)
maximal Histalog test A test for measurement of maximal production of gastric acidity or anacidity; it is similar to the histamine test, but uses Histalog (betazole hydrochloride), an analogue of histamine.
Synonym: maximal Histalog test.
(05 Mar 2000)
Mazzotti test A test for onchocerciasis using an oral test dose of diethylcarbamazine (50 or 100 mg), resulting in the appearance of an acute rash in 2 to 24 hours from death of microfilariae in the skin.
Synonym: Mazzotti reaction.
(05 Mar 2000)
McMurray test Rotation of the tibia on the femur to determine injury to meniscal structures.
(05 Mar 2000)
McNemar's test A form of chi-square test for matched paired data.
(05 Mar 2000)
McPhail test A test for progesterone and like substances; immature female rabbits are treated with 150 IU of estrone over a period of 6 days; the test material is then given in five daily subcutaneous doses; progestational proliferation of the endometrium is noted and the results estimated according to a scale from 0 to ++++; the amount required to produce an average (++) response is taken as a unit, equivalent to 0.25 mg of progesterone.
(05 Mar 2000)
passive cutaneous anaphylaxis test An animal is injected intradermally with antibody (usually IgE) and subsequently challenged intravenously with a mixture of antigen and Evans blue dye 24-48 hours later. A dark blue area indicates a positive reaction due to the leakage of the dye at the site of antigen-antibody reactions.
(05 Mar 2000)
patch test A test of skin sensitiveness: a small piece of paper, tape, or a cup, wet with CO non-irritating diluted test fluid, is applied to skin of the upper back or upper outer arm and after 48 hours the area previously covered is compared with the uncovered surface; an erythematous reaction with vesicles occurs if the substance causes contact allergy.
See: photo-patch test.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
ÅëÇÕ°Ë»ö ¿Ï·á